Kingworld Medicines Group Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended 30 June 2023

Kingworld Medicines Group Limited provided unaudited consolidated earnings guidance for the six months ended 30 June 2023. For the period, the Group is expected to record an increase in the profit of the Group by approximately
35% to 40% for the Period as compared to the profit of the Group of RMB 35.1 million for the six months ended 30 June 2022.